weight loss clinic glp 1 GLP-1 Options Medically Supervised GLP-1 Weight Loss

Some patients get low blood pressure and trouble breathing requiring hospitalization

32 The SOUL trial evaluated oral semaglutide in patients with T2D who had established atherosclerotic cardiovascular disease, chronic kidney disease (CKD), or both

Originally developed to treat type 2 diabetes, GLP-1 medications are now widely prescribed for weight loss

AT A GLANCE Originally FDA-approved for type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) also lead to sustained weight loss and have revolutionized diabetes and obesity management

The clinical criteria for determining eligibility for the Medicare GLP-1 Bridge are somewhat more restrictive than the FDA approvals, however, and include Part D enrollees with a BMI of 35 or more

One patient in the first group developed mild erythema on right side, which subsided within few hours without any treatment